British Journal of Cancer, ISSN 0007-0920, 09/2015, Volume 113, Issue 7, pp. 1035 - 1045
Background: Aberrant DNA methylation is more prominent in proximal compared with distal colorectal cancers. Although a number of methylation markers were...
DNA methylation; CpG methylator phenotype; CIMP; rectal cancer; epigenetic biomarker | CPG ISLAND METHYLATION | MICROSATELLITE INSTABILITY | rectal cancer | PHENOTYPE | epigenetic biomarker | RADIATION | CpG methylator phenotype | COLON-CANCER | KRAS MUTATIONS | GENE | ONCOLOGY | CIMP | COLORECTAL-CANCER | DNA methylation | EXPRESSION | CARCINOMA | Prognosis | Oligonucleotide Array Sequence Analysis - methods | Humans | Middle Aged | Male | Cyclin-Dependent Kinase Inhibitor p16 | DNA Methylation | Rectal Neoplasms - genetics | Survival Analysis | Aged, 80 and over | CpG Islands | Adult | Female | Aged | Biomarkers, Tumor - genetics | DNA, Neoplasm - analysis | Rectal Neoplasms - pathology | Neoplasm Proteins - genetics | Molecular Diagnostics
DNA methylation; CpG methylator phenotype; CIMP; rectal cancer; epigenetic biomarker | CPG ISLAND METHYLATION | MICROSATELLITE INSTABILITY | rectal cancer | PHENOTYPE | epigenetic biomarker | RADIATION | CpG methylator phenotype | COLON-CANCER | KRAS MUTATIONS | GENE | ONCOLOGY | CIMP | COLORECTAL-CANCER | DNA methylation | EXPRESSION | CARCINOMA | Prognosis | Oligonucleotide Array Sequence Analysis - methods | Humans | Middle Aged | Male | Cyclin-Dependent Kinase Inhibitor p16 | DNA Methylation | Rectal Neoplasms - genetics | Survival Analysis | Aged, 80 and over | CpG Islands | Adult | Female | Aged | Biomarkers, Tumor - genetics | DNA, Neoplasm - analysis | Rectal Neoplasms - pathology | Neoplasm Proteins - genetics | Molecular Diagnostics
Journal Article
Histopathology, ISSN 0309-0167, 02/2013, Volume 62, Issue 3, pp. 367 - 386
Approximately 30% of colorectal carcinomas develop via a serrated neoplasia pathway, named for the pattern of crypts in the precursor polyps. Molecular...
histopathology | serrated neoplasia pathway | large intestine | colorectal neoplasms | colonic polyps | Histopathology | Colorectal neoplasms | Serrated neoplasia pathway | Colonic polyps | Large intestine | HYPERPLASTIC POLYPS | EARLY NEOPLASTIC PROGRESSION | PATHOLOGY | MICROSATELLITE-INSTABILITY | CELLULAR SENESCENCE | CELL BIOLOGY | ISLAND METHYLATOR PHENOTYPE | COLON-CANCER | BRAF MUTATION | LOW CIMP-LOW | FIBROBLASTIC POLYP | PATHOLOGICAL FEATURES | Colonic Polyps - genetics | Colonic Polyps - pathology | Colorectal Neoplasms - genetics | Humans | Precancerous Conditions - metabolism | Precancerous Conditions - pathology | Colonic Polyps - metabolism | Colorectal Neoplasms - pathology | Precancerous Conditions - genetics | Colorectal Neoplasms - metabolism | Carcinoma | Gene mutations | Colorectal cancer | Development and progression | Methylation | Histochemistry | Cancer
histopathology | serrated neoplasia pathway | large intestine | colorectal neoplasms | colonic polyps | Histopathology | Colorectal neoplasms | Serrated neoplasia pathway | Colonic polyps | Large intestine | HYPERPLASTIC POLYPS | EARLY NEOPLASTIC PROGRESSION | PATHOLOGY | MICROSATELLITE-INSTABILITY | CELLULAR SENESCENCE | CELL BIOLOGY | ISLAND METHYLATOR PHENOTYPE | COLON-CANCER | BRAF MUTATION | LOW CIMP-LOW | FIBROBLASTIC POLYP | PATHOLOGICAL FEATURES | Colonic Polyps - genetics | Colonic Polyps - pathology | Colorectal Neoplasms - genetics | Humans | Precancerous Conditions - metabolism | Precancerous Conditions - pathology | Colonic Polyps - metabolism | Colorectal Neoplasms - pathology | Precancerous Conditions - genetics | Colorectal Neoplasms - metabolism | Carcinoma | Gene mutations | Colorectal cancer | Development and progression | Methylation | Histochemistry | Cancer
Journal Article
Gastroenterology, ISSN 0016-5085, 2010, Volume 138, Issue 6, pp. 2088 - 2100
The “serrated neoplastic pathway” describes the progression of serrated polyps, including sessile serrated adenomas and traditional serrated adenomas, to...
Gastroenterology and Hepatology | Colorectal Cancer | Hyperplastic Polyposis | Serrated Polyp | SPORADIC COLON-CANCER | DNA METHYLATION | MICROSATELLITE INSTABILITY | BRAF V600E MUTATION | PROMOTER POLYMORPHISM | ISLAND METHYLATOR PHENOTYPE | KRAS MUTATIONS | LOW CIMP-LOW | GASTROENTEROLOGY & HEPATOLOGY | ABERRANT CRYPT FOCI | Predictive Value of Tests | Microsatellite Instability | Prognosis | Adenoma - genetics | Colonic Polyps - pathology | Colorectal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Adenoma - therapy | Colonic Polyps - genetics | Cell Transformation, Neoplastic - genetics | Colonoscopy | Precancerous Conditions - pathology | Genetic Predisposition to Disease | Precancerous Conditions - therapy | Risk Assessment | Risk Factors | Colorectal Neoplasms - prevention & control | Precancerous Conditions - genetics | Animals | Biopsy | Adenoma - pathology | Mutation | Cell Transformation, Neoplastic - pathology | Colonic Polyps - therapy | Colorectal Neoplasms - pathology | Development and progression | Protein kinases | Colorectal cancer | Protein binding
Gastroenterology and Hepatology | Colorectal Cancer | Hyperplastic Polyposis | Serrated Polyp | SPORADIC COLON-CANCER | DNA METHYLATION | MICROSATELLITE INSTABILITY | BRAF V600E MUTATION | PROMOTER POLYMORPHISM | ISLAND METHYLATOR PHENOTYPE | KRAS MUTATIONS | LOW CIMP-LOW | GASTROENTEROLOGY & HEPATOLOGY | ABERRANT CRYPT FOCI | Predictive Value of Tests | Microsatellite Instability | Prognosis | Adenoma - genetics | Colonic Polyps - pathology | Colorectal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Adenoma - therapy | Colonic Polyps - genetics | Cell Transformation, Neoplastic - genetics | Colonoscopy | Precancerous Conditions - pathology | Genetic Predisposition to Disease | Precancerous Conditions - therapy | Risk Assessment | Risk Factors | Colorectal Neoplasms - prevention & control | Precancerous Conditions - genetics | Animals | Biopsy | Adenoma - pathology | Mutation | Cell Transformation, Neoplastic - pathology | Colonic Polyps - therapy | Colorectal Neoplasms - pathology | Development and progression | Protein kinases | Colorectal cancer | Protein binding
Journal Article
International Journal of Cancer, ISSN 0020-7136, 07/2016, Volume 139, Issue 2, pp. 424 - 432
MGMT promoter methylation status is currently the only established molecular prognosticator in IDH wild‐type glioblastoma multiforme (GBM). Therefore, we aimed...
brain tumor | G‐CIMP | biomarker | methylation | G-CIMP | GLIOMAS | LONG-TERM SURVIVAL | KINASE | DOWN-REGULATION | CPG METHYLATION | MULTIFORME | ADJUVANT TEMOZOLOMIDE | ONCOLOGY | CONCOMITANT | RADIOTHERAPY | MUTATIONS | Promoter Regions, Genetic | Genome-Wide Association Study | Reproducibility of Results | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Kaplan-Meier Estimate | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Male | Chemoradiotherapy | Glioblastoma - therapy | Young Adult | DNA Methylation | Glioblastoma - genetics | Brain Neoplasms - therapy | Aged, 80 and over | CpG Islands | Adult | Female | Aged | Brain Neoplasms - mortality | Glioblastoma - mortality | Epigenetic inheritance | Methylation | Glioblastoma multiforme | Patient outcomes | Radiology | Biomarkers | Chemotherapy | Brain cancer | Mortality | Immunoprecipitation | Profiling | DNA probes | Genes | Glioblastoma | Independent study | Patients | Survival | Surgery | DNA methylation | Epigenetics | DNA fingerprinting | Probes | Deoxyribonucleic acid--DNA | CpG islands
brain tumor | G‐CIMP | biomarker | methylation | G-CIMP | GLIOMAS | LONG-TERM SURVIVAL | KINASE | DOWN-REGULATION | CPG METHYLATION | MULTIFORME | ADJUVANT TEMOZOLOMIDE | ONCOLOGY | CONCOMITANT | RADIOTHERAPY | MUTATIONS | Promoter Regions, Genetic | Genome-Wide Association Study | Reproducibility of Results | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Kaplan-Meier Estimate | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Male | Chemoradiotherapy | Glioblastoma - therapy | Young Adult | DNA Methylation | Glioblastoma - genetics | Brain Neoplasms - therapy | Aged, 80 and over | CpG Islands | Adult | Female | Aged | Brain Neoplasms - mortality | Glioblastoma - mortality | Epigenetic inheritance | Methylation | Glioblastoma multiforme | Patient outcomes | Radiology | Biomarkers | Chemotherapy | Brain cancer | Mortality | Immunoprecipitation | Profiling | DNA probes | Genes | Glioblastoma | Independent study | Patients | Survival | Surgery | DNA methylation | Epigenetics | DNA fingerprinting | Probes | Deoxyribonucleic acid--DNA | CpG islands
Journal Article
Technology in Cancer Research and Treatment, ISSN 1533-0346, 01/2015, Volume 14, Issue 4, pp. 383 - 394
Journal Article
Annals of Oncology, ISSN 0923-7534, 12/2014, Volume 25, Issue 12, pp. 2314 - 2327
Background: Divergent findings regarding the prognostic value of CpG island methylator phenotype (CIMP) in colorectal cancer (CRC) patients exist in current...
adjuvant chemotherapy | colorectal cancer | tumor marker | prognosis | CIMP | epigenetics | Tumor marker | Epigenetics | Adjuvant chemotherapy | Prognosis | Colorectal cancer | HYPERMETHYLATION | SURVIVAL BENEFIT | MICROSATELLITE INSTABILITY | CLASSIFICATION | STAGE-II | COLON-CANCER | 5-FLUOROURACIL | ONCOLOGY | BRAF MUTATION | ASSOCIATION | DNA Methylation | Phenotype | Colorectal Neoplasms - genetics | Humans | CpG Islands | Colorectal Neoplasms - pathology | Reviews
adjuvant chemotherapy | colorectal cancer | tumor marker | prognosis | CIMP | epigenetics | Tumor marker | Epigenetics | Adjuvant chemotherapy | Prognosis | Colorectal cancer | HYPERMETHYLATION | SURVIVAL BENEFIT | MICROSATELLITE INSTABILITY | CLASSIFICATION | STAGE-II | COLON-CANCER | 5-FLUOROURACIL | ONCOLOGY | BRAF MUTATION | ASSOCIATION | DNA Methylation | Phenotype | Colorectal Neoplasms - genetics | Humans | CpG Islands | Colorectal Neoplasms - pathology | Reviews
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 149, Issue 5, pp. 1177 - 1190.e3
Sporadic colorectal cancer (CRC) is a somatic genetic disease in which pathogenesis is influenced by the local colonic environment and the patient’s genetic...
Gastroenterology and Hepatology | Genomic Instability | Microsatellite Instability | Chromosomal Instability | CIMP | MISMATCH-REPAIR DEFICIENCY | BONE MORPHOGENETIC PROTEIN | CPG ISLAND | SUSCEPTIBILITY LOCI | RANDOMIZED-TRIAL | MICROSATELLITE-INSTABILITY | STAGE-II | ISLAND METHYLATOR PHENOTYPE | COLON-CANCER | GASTROENTEROLOGY & HEPATOLOGY | GENOME-WIDE ASSOCIATION | DNA Methylation | Genetic Predisposition to Disease | Prognosis | Colorectal Neoplasms - genetics | Humans | MicroRNAs | Gene Expression Regulation, Neoplastic | CpG Islands | Genetic Markers | Mutation | Genome-Wide Association Study - methods | Epigenetic inheritance | Genomics | Colorectal cancer | Genetic research | Genetic aspects | Tumor proteins | Biological markers | Cancer | microsatellite instability | genomic instability | chromosomal instability
Gastroenterology and Hepatology | Genomic Instability | Microsatellite Instability | Chromosomal Instability | CIMP | MISMATCH-REPAIR DEFICIENCY | BONE MORPHOGENETIC PROTEIN | CPG ISLAND | SUSCEPTIBILITY LOCI | RANDOMIZED-TRIAL | MICROSATELLITE-INSTABILITY | STAGE-II | ISLAND METHYLATOR PHENOTYPE | COLON-CANCER | GASTROENTEROLOGY & HEPATOLOGY | GENOME-WIDE ASSOCIATION | DNA Methylation | Genetic Predisposition to Disease | Prognosis | Colorectal Neoplasms - genetics | Humans | MicroRNAs | Gene Expression Regulation, Neoplastic | CpG Islands | Genetic Markers | Mutation | Genome-Wide Association Study - methods | Epigenetic inheritance | Genomics | Colorectal cancer | Genetic research | Genetic aspects | Tumor proteins | Biological markers | Cancer | microsatellite instability | genomic instability | chromosomal instability
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2016, Volume 22, Issue 13, pp. 3516 - 3530
Molecular advances support the existence of an alternative pathway of colorectal carcinogenesis that is based on the hypermethylation of specific DNA regions...
Colorectal | pathway;Chemotherapy;CIMP | phenotype;Serrated | cancer;Methylator | Serrated pathway | Chemotherapy | CIMP | Colorectal cancer | Methylator phenotype | ADJUVANT CHEMOTHERAPY | BRAF MUTATION STATUS | 1ST-LINE TREATMENT | HYPERPLASTIC POLYPS | III COLON-CANCER | DNA METHYLATION | MISMATCH REPAIR | MICROSATELLITE-INSTABILITY | ISLAND METHYLATOR PHENOTYPE | CETUXIMAB PLUS IRINOTECAN | GASTROENTEROLOGY & HEPATOLOGY | Predictive Value of Tests | Genetic Predisposition to Disease | Microsatellite Instability | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Humans | Treatment Outcome | Antineoplastic Agents - therapeutic use | Colorectal Neoplasms - classification | DNA Methylation | Molecular Diagnostic Techniques | Phenotype | Proto-Oncogene Proteins B-raf - genetics | Colorectal Neoplasms - drug therapy | CpG Islands | Biomarkers, Tumor - genetics | Mutation | Colorectal Neoplasms - pathology | Neoplasm Staging | Index Medicus | Review
Colorectal | pathway;Chemotherapy;CIMP | phenotype;Serrated | cancer;Methylator | Serrated pathway | Chemotherapy | CIMP | Colorectal cancer | Methylator phenotype | ADJUVANT CHEMOTHERAPY | BRAF MUTATION STATUS | 1ST-LINE TREATMENT | HYPERPLASTIC POLYPS | III COLON-CANCER | DNA METHYLATION | MISMATCH REPAIR | MICROSATELLITE-INSTABILITY | ISLAND METHYLATOR PHENOTYPE | CETUXIMAB PLUS IRINOTECAN | GASTROENTEROLOGY & HEPATOLOGY | Predictive Value of Tests | Genetic Predisposition to Disease | Microsatellite Instability | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Humans | Treatment Outcome | Antineoplastic Agents - therapeutic use | Colorectal Neoplasms - classification | DNA Methylation | Molecular Diagnostic Techniques | Phenotype | Proto-Oncogene Proteins B-raf - genetics | Colorectal Neoplasms - drug therapy | CpG Islands | Biomarkers, Tumor - genetics | Mutation | Colorectal Neoplasms - pathology | Neoplasm Staging | Index Medicus | Review
Journal Article
Gut, ISSN 0017-5749, 06/2012, Volume 61, Issue 6, pp. 847 - 854
ObjectiveColorectal cancer is typically classified into proximal colon, distal colon and rectal cancer. Tumour genetic and epigenetic features differ by tumour...
ISLAND METHYLATOR PHENOTYPE | DNA METHYLATION | LINE-1 HYPOMETHYLATION | GENE | BRAF MUTATION | MICROSATELLITE INSTABILITY | CIMP | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | COLONIC-MUCOSA | P-GLYCOPROTEIN | ras Proteins - genetics | Colonic Neoplasms - genetics | Microsatellite Instability | Proto-Oncogene Proteins p21(ras) | Cecal Neoplasms - pathology | Colorectal Neoplasms - genetics | Humans | Long Interspersed Nucleotide Elements - genetics | Male | Colonic Neoplasms - metabolism | Sigmoid Neoplasms - genetics | Rectal Neoplasms - genetics | Female | Rectal Neoplasms - pathology | Colorectal Neoplasms - metabolism | Cecal Neoplasms - genetics | Mutation Rate | Proto-Oncogene Proteins - genetics | DNA Methylation - genetics | Mutation - genetics | Phosphatidylinositol 3-Kinases - genetics | Class I Phosphatidylinositol 3-Kinases | Proto-Oncogene Proteins B-raf - genetics | Colonic Neoplasms - pathology | CpG Islands - genetics | Aged | Rectal Neoplasms - metabolism | DNA, Neoplasm - genetics | Colorectal Neoplasms - pathology | Sigmoid Neoplasms - pathology | Development and progression | Genetic aspects | Colon (Anatomy) | Research | Gene mutations | Colorectal cancer | Medical personnel | Studies | Hypotheses | Hospitals | Biopsy | Rodents | Epigenetics | Mutation | Data bases | Tumors | Index Medicus | Abridged Index Medicus
ISLAND METHYLATOR PHENOTYPE | DNA METHYLATION | LINE-1 HYPOMETHYLATION | GENE | BRAF MUTATION | MICROSATELLITE INSTABILITY | CIMP | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | COLONIC-MUCOSA | P-GLYCOPROTEIN | ras Proteins - genetics | Colonic Neoplasms - genetics | Microsatellite Instability | Proto-Oncogene Proteins p21(ras) | Cecal Neoplasms - pathology | Colorectal Neoplasms - genetics | Humans | Long Interspersed Nucleotide Elements - genetics | Male | Colonic Neoplasms - metabolism | Sigmoid Neoplasms - genetics | Rectal Neoplasms - genetics | Female | Rectal Neoplasms - pathology | Colorectal Neoplasms - metabolism | Cecal Neoplasms - genetics | Mutation Rate | Proto-Oncogene Proteins - genetics | DNA Methylation - genetics | Mutation - genetics | Phosphatidylinositol 3-Kinases - genetics | Class I Phosphatidylinositol 3-Kinases | Proto-Oncogene Proteins B-raf - genetics | Colonic Neoplasms - pathology | CpG Islands - genetics | Aged | Rectal Neoplasms - metabolism | DNA, Neoplasm - genetics | Colorectal Neoplasms - pathology | Sigmoid Neoplasms - pathology | Development and progression | Genetic aspects | Colon (Anatomy) | Research | Gene mutations | Colorectal cancer | Medical personnel | Studies | Hypotheses | Hospitals | Biopsy | Rodents | Epigenetics | Mutation | Data bases | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 11/2018, Volume 9, Issue 86, pp. 35609 - 35610
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2009, Volume 27, Issue 9, pp. 1477 - 1484
Purpose PIK3CA mutation and subsequent activation of the AKT pathway play an important role in colorectal carcinogenesis. However, little is known about the...
ISLAND METHYLATOR PHENOTYPE | KRAS MUTATIONS | SURVIVAL | CETUXIMAB | POPULATION | GENE | ONCOLOGY | COLORECTAL-CANCER | MICROSATELLITE INSTABILITY | CIMP | EXPRESSION | Colonic Neoplasms - genetics | Prognosis | Humans | Male | Phosphatidylinositol 3-Kinases - genetics | Colonic Neoplasms - surgery | Class I Phosphatidylinositol 3-Kinases | Proto-Oncogene Proteins B-raf - genetics | Colonic Neoplasms - pathology | Female | Aged | Biomarkers, Tumor - genetics | Colonic Neoplasms - enzymology | Mutation | Genes, ras | Neoplasm Staging | Index Medicus | To15 | Original Reports | To8 | To11 | To2 | Gic7
ISLAND METHYLATOR PHENOTYPE | KRAS MUTATIONS | SURVIVAL | CETUXIMAB | POPULATION | GENE | ONCOLOGY | COLORECTAL-CANCER | MICROSATELLITE INSTABILITY | CIMP | EXPRESSION | Colonic Neoplasms - genetics | Prognosis | Humans | Male | Phosphatidylinositol 3-Kinases - genetics | Colonic Neoplasms - surgery | Class I Phosphatidylinositol 3-Kinases | Proto-Oncogene Proteins B-raf - genetics | Colonic Neoplasms - pathology | Female | Aged | Biomarkers, Tumor - genetics | Colonic Neoplasms - enzymology | Mutation | Genes, ras | Neoplasm Staging | Index Medicus | To15 | Original Reports | To8 | To11 | To2 | Gic7
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2012, Volume 131, Issue 4, pp. 779 - 788
Colorectal cancer (CRC) is one of the most common causes of cancer‐related deaths in western countries. CRC are commonly divided in cancers showing...
high expression | SMAD4 | MSI | colon cancer | CIMP | TGF-BETA | CIMP-LOW | PHENOTYPE | LIVER METASTASIS | HUMAN COLORECTAL-CANCER | GROWTH-FACTOR-BETA | ONCOLOGY | BRAF MUTATION | PROTEIN EXPRESSION | GENES | IMMUNOHISTOCHEMISTRY | Immunohistochemistry | Colonic Neoplasms - genetics | Microsatellite Instability | Prognosis | Humans | Middle Aged | Male | Smad4 Protein - metabolism | Colonic Neoplasms - metabolism | DNA Methylation | Chromosomes, Human, Pair 18 | Colonic Neoplasms - pathology | Aged, 80 and over | Female | Aged | Medical prognosis | Colorectal cancer | Tumors
high expression | SMAD4 | MSI | colon cancer | CIMP | TGF-BETA | CIMP-LOW | PHENOTYPE | LIVER METASTASIS | HUMAN COLORECTAL-CANCER | GROWTH-FACTOR-BETA | ONCOLOGY | BRAF MUTATION | PROTEIN EXPRESSION | GENES | IMMUNOHISTOCHEMISTRY | Immunohistochemistry | Colonic Neoplasms - genetics | Microsatellite Instability | Prognosis | Humans | Middle Aged | Male | Smad4 Protein - metabolism | Colonic Neoplasms - metabolism | DNA Methylation | Chromosomes, Human, Pair 18 | Colonic Neoplasms - pathology | Aged, 80 and over | Female | Aged | Medical prognosis | Colorectal cancer | Tumors
Journal Article